Advances in the role of microRNAs in lipid metabolism-related anti-atherosclerotic drug discovery

Bibliography

• Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science 2001;294:853-8
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843-54
   PubMed Web of Science ®Google Scholar
• Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993;75:855-62
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE, Reinhart BJ, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000;408:86-9
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39:D152-7
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775-89
   PubMed Web of Science ®Google Scholar
• Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011;469:336-42
   PubMed Web of Science ®Google Scholar
• Natarajan R, Putta S, Kato M. MicroRNAs and diabetic complications. J Cardiovasc Transl Res 2012;5:413-22
   PubMed Web of Science ®Google Scholar
• Stenvang J, Petri A, Lindow M, et al. Inhibition of microRNA function by antimiR oligonucleotides. Silence 2012;3:1
   PubMedGoogle Scholar
• Delivering therapies for patients with unmet medical needs. Santaris Pharma A/S, San Diego, CA; 2013. Available from: http://www.santaris.com/
   Google Scholar
• Lindow M, Kauppinen S. Discovering the first microRNA-targeted drug. J Cell Biol 2012;199:407-12
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Suarez Y, Davalos A, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010;328:1570-3
   PubMed Web of Science ®Google Scholar
• Marquart TJ, Allen RM, Ory DS, et al. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 2010;107:12228-32
   PubMed Web of Science ®Google Scholar
• Najafi-Shoushtari SH, Kristo F, Li Y, et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010;328:1566-9
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051-60
   PubMed Web of Science ®Google Scholar
• Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006;13:1097-101
   PubMed Web of Science ®Google Scholar
• Kim YK, Kim VN. Processing of intronic microRNAs. EMBO J 2007;26:775-83
   PubMed Web of Science ®Google Scholar
• Mourelatos Z. Small RNAs: the seeds of silence. Nature 2008;455:44-5
   PubMed Web of Science ®Google Scholar
• Lee Y, Jeon K, Lee JT, et al. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002;21:4663-70
   PubMed Web of Science ®Google Scholar
• Denli AM, Tops BB, Plasterk RH, et al. Processing of primary microRNAs by the Microprocessor complex. Nature 2004;432:231-5
   PubMed Web of Science ®Google Scholar
• Han J, Lee Y, Yeom KH, et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004;18:3016-27
   PubMed Web of Science ®Google Scholar
• Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004;10:185-91
   PubMed Web of Science ®Google Scholar
• Bernstein E, Caudy AA, Hammond SM, et al. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001;409:363-6
   PubMed Web of Science ®Google Scholar
• Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005;436:740-4
   PubMed Web of Science ®Google Scholar
• Lau NC, Lim LP, Weinstein EG, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001;294:858-62
   PubMed Web of Science ®Google Scholar
• Schwarz DS, Hutvagner G, Du T, et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003;115:199-208
   PubMed Web of Science ®Google Scholar
• Kawamata T, Seitz H, Tomari Y. Structural determinants of miRNAs for RISC loading and slicer-independent unwinding. Nat Struct Mol Biol 2009;16:953-60
   PubMed Web of Science ®Google Scholar
• Chang KW, Kao SY, Wu YH, et al. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Oral Oncol 2013;49:27-33
   PubMed Web of Science ®Google Scholar
• Shin C, Nam JW, Farh KK, et al. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010;38:789-802
   PubMed Web of Science ®Google Scholar
• Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007;17:118-26
   PubMed Web of Science ®Google Scholar
• Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol 2008;20:214-21
   PubMed Web of Science ®Google Scholar
• Guo H, Ingolia NT, Weissman JS, et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010;466:835-40
   PubMed Web of Science ®Google Scholar
• Libby P. Atherosclerosis: the new view. Sci Am 2002;286:46-55
   PubMed Web of Science ®Google Scholar
• Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47
   PubMed Web of Science ®Google Scholar
• Khera AV, Rader DJ. Future therapeutic directions in reverse cholesterol transport. Curr Atheroscler Rep 2010;12:73-81
   PubMed Web of Science ®Google Scholar
• Wang X, Collins HL, Ranalletta M, et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 2007;117:2216-24
   PubMed Web of Science ®Google Scholar
• Ji A, Wroblewski JM, Cai L, et al. Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI. J Lipid Res 2012;53:446-55
   PubMed Web of Science ®Google Scholar
• Connelly MA, Williams DL. SR-BI and cholesterol uptake into steroidogenic cells. Trends Endocrinol Metab 2003;14:467-72
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423-33
   PubMed Web of Science ®Google Scholar
• Davalos A, Goedeke L, Smibert P, et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA 2011;108:9232-7
   PubMed Web of Science ®Google Scholar
• Wang MD, Franklin V, Sundaram M, et al. Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages. J Biol Chem 2007;282:22525-33
   PubMedGoogle Scholar
• Horie T, Ono K, Horiguchi M, et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA 2010;107:17321-6
   PubMed Web of Science ®Google Scholar
• Horie T, Baba O, Kuwabara Y, et al. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice. J Am Heart Assoc 2012;1:e003376
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Sheedy FJ, Esau CC, et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 2011;121:2921-31
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Esau CC, Hussain FN, et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011;478:404-7
   PubMed Web of Science ®Google Scholar
• Ramirez CM, Davalos A, Goedeke L, et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 2011;31:2707-14
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon H, Ramirez CM, et al. MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp Neurol 2012;235:476-83
   PubMed Web of Science ®Google Scholar
• Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000;14:121-41
   PubMed Web of Science ®Google Scholar
• Sun D, Zhang J, Xie J, et al. MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett 2012;586:1472-9
   Google Scholar
• Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999-3004
   PubMed Web of Science ®Google Scholar
• Mohamed JS, Lopez MA, Boriek AM. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J Biol Chem 2010;285:29336-47
   PubMed Web of Science ®Google Scholar
• Wang D, Zou T, Yang Y, et al. Cyanidin-3-O-beta-glucoside with the aid of its metabolite protocatechuic acid, reduces monocyte infiltration in apolipoprotein E-deficient mice. Biochem Pharmacol 2011;82:713-19
   PubMed Web of Science ®Google Scholar
• Wang D, Xia M, Yan X, et al. Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circ Res 2012;111:967-81
   PubMed Web of Science ®Google Scholar
• Bidzhekov K, Gan L, Denecke B, et al. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost 2012;107:619-25
   Google Scholar
• Hoekstra M, van der Sluis RJ, Kuiper J, et al. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. J Nutr Biochem 2012;23:622-8
   PubMed Web of Science ®Google Scholar
• Matsuzaka T, Shimano H, Yahagi N, et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med 2007;13:1193-202
   PubMed Web of Science ®Google Scholar
• Wang L, Jia XJ, Jiang HJ, et al. MiRNA-185, MiRNA-96 and MiRNA-223 repress selective HDL-Cholesterol uptake through posttranscriptional inhibition of scavenger receptor class BI in hepatic cells. Mol Cell Biol 2013;33(10):1956-64
   PubMed Web of Science ®Google Scholar
• Perri R, Nares S, Zhang S, et al. MicroRNA modulation in obesity and periodontitis. J Dent Res 2012;91:33-8
   PubMed Web of Science ®Google Scholar
• Hu Z, Shen WJ, Kraemer FB, et al. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Mol Cell Biol 2012;32:5035-45
   PubMed Web of Science ®Google Scholar
• Chen T, Huang Z, Wang L, et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 2009;83:131-9
   PubMed Web of Science ®Google Scholar
• Im YJ, Raychaudhuri S, Prinz WA, et al. Structural mechanism for sterol sensing and transport by OSBP-related proteins. Nature 2005;437:154-8
   PubMed Web of Science ®Google Scholar
• Laffitte BA, Joseph SB, Walczak R, et al. Autoregulation of the human liver X receptor alpha promoter. Mol Cell Biol 2001;21:7558-68
   PubMed Web of Science ®Google Scholar
• Wang XJ, Reyes JL, Chua NH, et al. Prediction and identification of Arabidopsis thaliana microRNAs and their mRNA targets. Genome Biol 2004;5:R65
   PubMedGoogle Scholar
• Ou Z, Wada T, Gramignoli R, et al. MicroRNA hsa-miR-613 targets the human LXRalpha gene and mediates a feedback loop of LXRalpha autoregulation. Mol Endocrinol 2011;25:584-96
   PubMed Web of Science ®Google Scholar
• Repa JJ, Liang G, Ou J, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000;14:2819-30
   PubMed Web of Science ®Google Scholar
• Zhang L, Hou D, Chen X, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 2012;22:107-26
   PubMed Web of Science ®Google Scholar
• Garcia CK, Wilund K, Arca M, et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 2001;292:1394-8
   PubMed Web of Science ®Google Scholar
• Brodersen P, Sakvarelidze-Achard L, Bruun-Rasmussen M, et al. Widespread translational inhibition by plant miRNAs and siRNAs. Science 2008;320:1185-90
   PubMed Web of Science ®Google Scholar
• Chang J, Nicolas E, Marks D, et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 2004;1:106-13
   PubMedGoogle Scholar
• Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002;12:735-9
   PubMed Web of Science ®Google Scholar
• Hsu SH, Wang B, Kota J, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 2012;122:2871-83
   PubMed Web of Science ®Google Scholar
• Tsai WC, Hsu SD, Hsu CS, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 2012;122:2884-97
   PubMed Web of Science ®Google Scholar
• Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87-98
   PubMed Web of Science ®Google Scholar
• Elmen J, Lindow M, Schutz S, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008;452:896-9
   PubMed Web of Science ®Google Scholar
• Elmen J, Lindow M, Silahtaroglu A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008;36:1153-62
   PubMed Web of Science ®Google Scholar
• Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010;327:198-201
   PubMed Web of Science ®Google Scholar
• Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with ‘antagomirs'. Nature 2005;438:685-9
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Drosatos K, Hiyama Y, et al. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010;51:1513-23
   PubMed Web of Science ®Google Scholar
• Li S, Zhu J, Fu H, et al. Hepato-specific microRNA-122 facilitates accumulation of newly synthesized miRNA through regulating PRKRA. Nucleic Acids Res 2012;40:884-91
   PubMed Web of Science ®Google Scholar
• Huang RS, Hu GQ, Lin B, et al. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med 2010;58:961-7
   PubMed Web of Science ®Google Scholar
• Kurowska-Stolarska M, Alivernini S, Ballantine LE, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci USA 2011;108:11193-8
   PubMed Web of Science ®Google Scholar
• Wei Y, Nazari-Jahantigh M, Neth P, et al. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol 2013;33:449-54
   PubMed Web of Science ®Google Scholar
• Yang K, He YS, Wang XQ, et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett 2011;585:854-60
   PubMed Web of Science ®Google Scholar
• Ghani S, Riemke P, Schonheit J, et al. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood 2011;118:2275-84
   PubMed Web of Science ®Google Scholar
• Pioneering microRNA Replacement Therapies. Mirna Therapeutics, Austin, TX; 2013. Available from: http://www.mirnarx.com/
   Google Scholar
• Liu YP, Berkhout B. miRNA cassettes in viral vectors: problems and solutions. Biochim Biophys Acta 2011;1809:732-45
   PubMed Web of Science ®Google Scholar
• Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4:721-6
   PubMed Web of Science ®Google Scholar
• Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA 2010;16:2043-50
   PubMed Web of Science ®Google Scholar
• Xu L, Anchordoquy T. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci 2011;100:38-52
   PubMed Web of Science ®Google Scholar
• Deleavey GF, Damha MJ. Designing chemically modified oligonucleotides for targeted gene silencing. Chem Biol 2012;19:937-54
   PubMed Web of Science ®Google Scholar
• Karkare S, Bhatnagar D. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino. Appl Microbiol Biotechnol 2006;71:575-86
   PubMed Web of Science ®Google Scholar
• Obad S, dos Santos CO, Petri A, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 2011;43:371-8
   PubMed Web of Science ®Google Scholar
• Connelly CM, Thomas M, Deiters A. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function. J Biomol Screen 2012;17:822-8
   PubMed Web of Science ®Google Scholar
• Chen L, Calin GA, Zhang S. Novel insights of structure-based modeling for RNA-targeted drug discovery. J Chem Inf Model 2012;52:2741-53
   PubMed Web of Science ®Google Scholar
• Gumireddy K, Young DD, Xiong X, et al. Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 2008;47:7482-4
   PubMed Web of Science ®Google Scholar
• Young DD, Connelly CM, Grohmann C, et al. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc 2010;132:7976-81
   PubMed Web of Science ®Google Scholar
• Bose D, Jayaraj G, Suryawanshi H, et al. The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. Angew Chem Int Ed Engl 2012;51:1019-23
   PubMed Web of Science ®Google Scholar
• Davies BP, Arenz C. A homogenous assay for micro RNA maturation. Angew Chem Int Ed Engl 2006;45:5550-2
   PubMed Web of Science ®Google Scholar
• Davies BP, Arenz C. A fluorescence probe for assaying micro RNA maturation. Bioorg Med Chem 2008;16:49-55
   PubMed Web of Science ®Google Scholar
• Chirayil S, Chirayil R, Luebke KJ. Discovering ligands for a microRNA precursor with peptoid microarrays. Nucleic Acids Res 2009;37:5486-97
   PubMed Web of Science ®Google Scholar
• Tan GS, Chiu CH, Garchow BG, et al. Small molecule inhibition of RISC loading. ACS Chem Biol 2012;7:403-10
   PubMed Web of Science ®Google Scholar
• Chiu YL, Dinesh CU, Chu CY, et al. Dissecting RNA-interference pathway with small molecules. Chem Biol 2005;12:643-8
   PubMed Web of Science ®Google Scholar
• Shan Z, Lin Q, Deng C, et al. An efficient method to enhance gene silencing by using precursor microRNA designed small hairpin RNAs. Mol Biol Rep 2009;36:1483-9
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang C, Xi Z. Enhancement of RNAi by a small molecule antibiotic enoxacin. Cell Res 2008;18:1077-9
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang L, Si S, et al. How can high-throughput screening deliver drugs to treat atherosclerosis? Expert Opin Drug Discov 2010;5:1175-88
   PubMed Web of Science ®Google Scholar
• Limmer K, Aschenbrenner D, Gaub HE. Sequence-specific inhibition of Dicer measured with a force-based microarray for RNA ligands. Nucleic Acids Res 2013;41(6):e69
   PubMed Web of Science ®Google Scholar